Amgen
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Amgen generated cash of $8,471,000,000, which is less than the previous year. Cash used in financing activities reached the amount of $21,048,000,000 last year. Net change in cash is therefore $3,315,000,000.
Cash Flow
| 2014 | 8.55B | -5.75B | -2.87B |
|---|---|---|---|
| 2015 | 9.07B | -5.54B | -3.11B |
| 2016 | 10.35B | -8.65B | -2.59B |
| 2017 | 11.17B | -4.02B | -6.59B |
| 2018 | 11.29B | 14.33B | -22.49B |
| 2019 | 9.15B | 5.70B | -15.76B |
| 2020 | 10.49B | -5.40B | -4.86B |
| 2021 | 9.26B | 733M | -8.27B |
| 2022 | 9.72B | -6.04B | -4.03B |
| 2023 | 8.47B | -26.20B | 21.04B |
AMGN Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 7.62B | 7.98B | 6.26B | 6.03B | 6.94B | 3.8B | 3.24B | 4.14B | 3.73B | 3.80B |
Operating activities | ||||||||||
Net income | 6.71B | 6.55B | 5.89B | 7.26B | 7.84B | 8.39B | 1.97B | 7.72B | 6.93B | 5.15B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4.07B | 3.41B | 3.39B | 3.60B | 2.20B | 1.94B | 1.95B | 2.10B | 2.10B | 2.09B |
Stock-based compensation expense | 431M | 401M | 341M | 330M | 308M | 311M | 329M | 311M | 322M | 408M |
| Deferred income tax benefit | 431M | 401M | 341M | 330M | 308M | 311M | 329M | 311M | 322M | 408M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -746M | -429M | -427M | -504M | -378M | -58M | -214M | -420M | 136M |
Inventories | 491M | -742M | -165M | -215M | -66M | -3M | 133M | -80M | 481M | 327M |
Accounts payable | -402M | 154M | -69M | 45M | 164M | -143M | 424M | -44M | -12M | 405M |
Cash generated by operating activities | 8.47B | 9.72B | 9.26B | 10.49B | 9.15B | 11.29B | 11.17B | 10.35B | 9.07B | 8.55B |
Investing activities | ||||||||||
Purchases Of Investments | -1M | -2.58B | -8.9B | -8.47B | -9.39B | -18.74B | -33.60B | -28.09B | -25.97B | -25.87B |
Investments In Property Plant And Equipment | -1.11B | -936M | -880M | -608M | -618M | -738M | -664M | -837M | -649M | -1.00B |
Acquisitions Net | -26.98B | -3.72B | -2.68B | -3.21B | -13.61B | 195M | -19M | -21M | -359M | -165M |
Cash generated by investing activities | -26.20B | -6.04B | 733M | -5.40B | 5.70B | 14.33B | -4.02B | -8.65B | -5.54B | -5.75B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 8.91B | 0 | 0 | 0 | 0 | 82M | 186M |
Payments for dividends | -4.55B | -4.19B | -4.01B | -3.75B | -3.50B | -3.50B | -3.36B | -2.99B | -2.39B | -1.85B |
Repurchases of common stock | 0 | -6.36B | -4.97B | -3.48B | -7.70B | -17.79B | -3.16B | -3.22B | -1.86B | -138M |
Repayments of term debt | 25.67B | 6.62B | -795M | -6.45B | -4.51B | -1.12B | 71M | 3.59B | 1.06B | -5.60B |
Cash used in financing activities | 21.04B | -4.03B | -8.27B | -4.86B | -15.76B | -22.49B | -6.59B | -2.59B | -3.11B | -2.87B |
Net Change In Cash | 3.31B | -360M | 1.72B | 229M | -908M | 3.14B | 559M | -903M | 413M | -74M |
Cash at end of period | 10.94B | 7.62B | 7.98B | 6.26B | 6.03B | 6.94B | 3.8B | 3.24B | 4.14B | 3.73B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |